Gloria Su
About Gloria Su
Gloria Su is a Scientific Review Officer at the National Institutes of Health, with a robust background in cancer research and academia. She has held various academic positions at Columbia University Irving Medical Center and Johns Hopkins Medicine, contributing significantly to the understanding of pancreatic cancer genetics.
Work at National Institutes of Health
Gloria Su has been serving as a Scientific Review Officer at the National Institutes of Health since 2022. In this role, she is responsible for overseeing the review process of grant applications, ensuring that scientific proposals meet rigorous standards of quality and relevance. Her expertise in cancer research and genetics contributes to the evaluation of applications related to these fields.
Education and Expertise
Gloria Su earned her Doctor of Philosophy (PhD) in Immunology from the University of Chicago, where she studied from 1992 to 1997. She also holds a Bachelor of Arts (BA) in Biology from Northwestern University, obtained between 1988 and 1992. Her educational background provides a strong foundation for her extensive research in cancer genetics and tumor biology.
Background in Academia
Gloria Su has a significant academic background, having held various positions at Columbia University Irving Medical Center. She served as an Assistant Professor from 2003 to 2012, then as a Professor from 2017 to 2022, and as an Associate Professor from 2012 to 2017. Prior to her tenure at Columbia, she was an Assistant Professor at Johns Hopkins Medicine from 2000 to 2003 and a Postdoctoral Fellow from 1997 to 2000.
Research Contributions
Gloria Su's research has focused on pancreatic cancer and its genetic underpinnings. Her team reported that the loss of wild-type KRAS is linked to pancreatic cancer metastasis in both mice and humans. She also contributed to the understanding of the cancer genetics of intraductal papillary mucinous neoplasm (IPMN) and demonstrated that dysregulation of the PI3K-PTEN signaling pathway correlates with poor prognosis among IPMN patients.
Publications and Editorial Roles
Gloria Su has authored over 80 original and review articles in the field of cancer research. She has held editorial positions, including editor-in-chief and editorial board member for multiple peer-reviewed journals. Additionally, she has served as a chartered member of an NIH study section and has acted as an ad hoc reviewer for various grant agencies, including NIH and DOD.